News tagged with protease inhibitors
Soybeans soaked in warm water naturally release key cancer-fighting substance
Soybeans soaking in warm water could become a new "green" source for production of a cancer-fighting substance now manufactured in a complicated and time-consuming industrial process, scientists are reporting ...
May 09, 2012 |
5 / 5 (4) |
1
New molecule has potential to help treat genetic diseases and HIV
(PhysOrg.com) -- Chemists at The University of Texas at Austin have created a molecule that's so good at tangling itself inside the double helix of a DNA sequence that it can stay there for up to 16 days before ...
Feb 13, 2012 |
5 / 5 (3) |
0
|
US regulators approve new hepatitis C drug
US regulators on Friday approved the first new treatment for hepatitis C in more than a decade, a Merck pharmaceutical known as Victrelis, to be taken with the current two-drug regimen.
Medicine & Health / Medications
May 14, 2011 |
not rated yet |
2
US panel gives nod to Merck hepatitis C drug
A US government advisory committee on Wednesday unanimously voted to urge the Food and Drug Administration to approve a new drug made by Merck to fight hepatitis C, a disease which attacks the liver.
Medicine & Health / Medications
Apr 27, 2011 |
5 / 5 (1) |
0
First-ever covalent irreversible inhibition of a protease central to hepatitis C infection
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protea ...
Nov 28, 2010 |
not rated yet |
0
Putting the brakes on drug-resistant HIV
(PhysOrg.com) -- HIV-1 protease inhibitors were added as a component of highly active antiretroviral therapy (HAART) in the mid-1990s, and have played a key role in that treatment regimen ever since. However, ...
Sep 17, 2010 |
not rated yet |
0
Researchers restore missing protein in rare genetic brain disorder
UCSF researchers have successfully used protease inhibitors to restore to normal levels a key protein involved in early brain development. Reduced levels of that protein have been shown to cause the rare brain disorder lissencephaly, ...
Medicine & Health / Medical research
Sep 06, 2009 |
5 / 5 (2) |
3
HIV-1 protease inhibitor induced oxidative stress in pancreatic B-cells: thymoquinone protection
Researchers at the Tulane University School of Medicine, New Orleans, Louisiana have discovered that the HIV-1 protease inhibitors (PIs), such as nelfinavir included in highly active antiretroviral therapy (HAART) regimen ...
Medicine & Health / HIV & AIDS
Mar 25, 2009 |
5 / 5 (2) |
0
- Pages: 1
